Once aiming to double oncology pipeline, Servier`s US branch touts
12 Jan 2021 //
ENDPTS
Servier to acquire Agios Pharmaceuticals’ oncology assets for $2bn
22 Dec 2020 //
PRESS RELEASE
Servier to acquire Agios Pharmaceuticals’ oncology assets for $2bn
22 Dec 2020 //
SERVIER
Servier and MBC BioLabs Announce Winner of the 2020 Servier Golden Ticket
24 Sep 2020 //
PRNEWSWIRE
Oncodesign & Servier Reach a Key 1st Milestone in Their Partnership on LRRK2
17 Feb 2020 //
PRESS RELEASE
LONSURF®trifluridine/tipiracil Receives Marketing Authorization EU for Patient
05 Sep 2019 //
BUSINESSWIRE
Servier cleared to start US trials CAR-T therapy
10 Mar 2017 //
PMLIVE
OSE, Servier ink $10.7M deal to develop autoimmune drug
28 Dec 2016 //
FIERCE BIOTECH
Minerva Neurosciences Names Michael Davidson, M.D. as Chief Medical Officer
20 Dec 2016 //
GLOBENEWSWIRE
Servier Canada to market Daiichi Sankyo`s anti-coagulant edoxaban in Canada
27 Jun 2016 //
PHARMABIZ
Servier and Pfizer get rights to Cellectis cancer cell therapy
18 Nov 2015 //
REUTERS